These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 708994)

  • 1. Localization of vasodilator dopamine receptors in the canine hindlimb.
    Bell C; Stubbs A
    Br J Pharmacol; 1978 Oct; 64(2):253-7. PubMed ID: 708994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Responses of the canine hepatic arterial and portal venous vascular beds to dopamine.
    Richardson PD; Withrington PG
    Eur J Pharmacol; 1978 Apr; 48(4):337-49. PubMed ID: 206449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular dopamine receptors in the canine hindlimb.
    Bell C; Conway EL; Lang WJ; Padanyi R
    Br J Pharmacol; 1975 Oct; 55(2):167-72. PubMed ID: 1201374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of dopamine on the conductance of perfused vascular beds of the chloralosed cat.
    Hamilton TC
    Br J Pharmacol; 1972 Mar; 44(3):442-50. PubMed ID: 4402742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for dopaminergic vasodilator innervation of the canine paw pad.
    Bell C; Lang WJ
    Br J Pharmacol; 1979 Nov; 67(3):337-43. PubMed ID: 40651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is the renal vasodilatation induced by beta-adrenoceptor stimulants in the dog mediated through dopamine receptor?
    Bell C; Mya MK
    Experientia; 1977 May; 33(5):638-9. PubMed ID: 862800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the effects of the novel inotropic agent, ibopamine, with epinine, dopamine and fenoldopam on renal vascular dopamine receptors in the anesthetized dog.
    Nichols AJ; Smith JM; Shebuski RJ; Ruffolo RR
    J Pharmacol Exp Ther; 1987 Aug; 242(2):573-8. PubMed ID: 2886644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in direct effects of adrenergic stimuli on coronary, cutaneous, and muscular vessels.
    Mark AL; Abboud FM; Schmid PG; Heistad DD; Mayer HE
    J Clin Invest; 1972 Feb; 51(2):279-87. PubMed ID: 4400290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Demonstration of specific dopamine-1 receptor-mediated coronary vasodilation in the anesthetized dog.
    Kopia GA; Valocik RE
    J Pharmacol Exp Ther; 1989 Jan; 248(1):215-21. PubMed ID: 2563287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the neurogenic vasodilatation elicited by central dopamine receptor stimulation with pergolide.
    Lokhandwala MF; Kivlighn SD; Jandhyala BS
    J Pharmacol Exp Ther; 1984 Mar; 228(3):696-703. PubMed ID: 6707919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine produces forearm vasodilatation following alpha-adrenoceptor blockade by an action on vascular dopamine (DA1) receptors in man.
    Hughes AD; Thom SA; Woodall NM; Redman D; Sever PS
    J Hypertens; 1987 Jun; 5(3):337-40. PubMed ID: 2886541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine-induced vasodilatation in the isolated perfused rat kidney.
    Woodman OL; Lang WJ
    Arch Int Pharmacodyn Ther; 1980 Feb; 243(2):228-35. PubMed ID: 6103692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The antagonism by propranolol and alpha-methylpropranolol (ICI 77602) of vascular and cardiac responses to isoprenaline in anaesthetized dogs.
    Fitzgerald JD; O'Donnell SR
    Clin Exp Pharmacol Physiol; 1978; 5(6):579-86. PubMed ID: 719958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of propranolol-sensitive beta-adrenoceptor signaling after inhibition of nitric oxide synthesis.
    Whalen EJ; Bates JN; Johnson AK; Lewis SJ
    Br J Pharmacol; 2006 Apr; 147(7):755-64. PubMed ID: 16474417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consistent unmasking of dopamine-induced dilation of the canine femoral vascular bed.
    Listinsky JJ; Kohli JD; Goldberg LI
    J Pharmacol Exp Ther; 1980 Dec; 215(3):662-7. PubMed ID: 6108364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antagonism of the renal vasodilator activity of dopamine by metoclopramide.
    Hahn RA; Wardell JR
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Nov; 314(2):177-82. PubMed ID: 7453834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasodilator responses to dopamine in rat perfused mesentery are age-dependent.
    Wanstall JC; O'Donnell SR
    Br J Pharmacol; 1989 Sep; 98(1):302-8. PubMed ID: 2804550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The actions of dopamine and of sulpiride on regional blood flows in the rat kidney.
    Chapman BJ; Horn NM; Munday KA; Robertson MJ
    J Physiol; 1980 Jan; 298():437-52. PubMed ID: 7359426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IP66 (1[2-ethoxy-2-(3'-pyridyl)ethyl]-4-(2'-methoxy-phenyl)piperazine) enhances beta-adrenoceptor-induced vasodilatation in rat mesenteric vascular bed.
    Perretti F; Nediani C; Manzini S
    Arch Int Pharmacodyn Ther; 1990; 306():87-99. PubMed ID: 1963768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylprednisolone-induced vasodilatation in the isolated hind limb of dogs before and after adrenoceptor blockade.
    Williams JB; Pruett JK; Mote PS
    Arch Int Pharmacodyn Ther; 1988; 293():154-61. PubMed ID: 3421775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.